NCT04650542View on ClinicalTrials.gov

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

February 21, 2021

Primary Completion Date

August 13, 2021

Study Completion Date

August 13, 2021

Conditions
Drug-drug Interaction
Interventions
DRUG

HBI-3000

small molecule, multi-ion channel blocker

DRUG

Paroxetine

serotonin uptake inhibitor, CYP2D6 inhibitor

Trial Locations (2)

53095

Spaulding Clinical, West Bend

Unknown

Nucleus Network Pty Ltd., Melbourne

All Listed Sponsors
lead

HUYABIO International, LLC.

INDUSTRY

NCT04650542 - Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects | Biotech Hunter | Biotech Hunter